GZMB and neoplasm: In contrast, a significantly decreased granzyme B expression was detected in stage III (n = 47, p = 0.011 vs. stage I, p = 0.015 vs. stage II) and stages IV malignant tumor tissues (n = 11, p = 0.027 vs. stage I, p = 0.048 vs. stage II).